ST 1103

has a broad antimicrobial spectrum

Also Known As:

ST-1103; undecyl-(4-N,N,N-trimethylammonium-(R)-3-isovaleroyloxy)butanoate methanesulfonate

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Infections 01/01/1995 - "In conclusion, ST 1103 appears to be a promising candidate for treatment of cutaneous infections caused by mixed microbial pathogens." 01/01/1995 - "Since indirect evidence indicates a poor oral absorbtion, ST 1103 was topically administered to mice with skin infections caused by mixed inocula. "